Log-rank analyses (Table 3) indicated that potentially important factors were age (split at median, P=0.036), nodal status (P=0.035), cancer stage (I/II vs III/IV), metastases (both P<0.001) and laboratory measures (split as normal/abnormal according to laboratory reference ranges as per current clinical practise) as AST, alkaline phosphatase, albumin, LDH, WBC (all P<0.001), bilirubin (P=0.002), CA19-9 (P=0.005) and haemoglobin (P=0.009). This evidence concerns the gene ALB and cancer.